Kevin Zikaras
Corporate Officer/Principal bij TCR2 THERAPEUTICS INC.
Actieve functies van Kevin Zikaras
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | 01-06-2018 | - |
Loopbaan van Kevin Zikaras
Eerdere bekende functies van Kevin Zikaras
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Opleiding van Kevin Zikaras
| Bowdoin College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
| Weill Cornell Medical College | Graduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Corporate Officer/Principal | 3 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Kevin Zikaras
- Ervaring
